abrdn Life Sciences Investors Director Mahai Chris LaVictoire acquires $10,497.84 in common shares
HQL•Director buys common shares
- abrdn Life Sciences Investors director Mahai Chris LaVictoire bought 527 common shares at $19.92 each.
- LaVictoire held 527 common shares directly following the purchase.
